Has Dennis Thapa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,065 in general payments to Dennis Thapa, MD across 125 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dennis Thapa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dennis Thapa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dennis Thapa, MD

Pain Medicine · Dover, NHNPI 1013259175

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,939 of the $13,065 with a category attached, or 60.8%. 16 manufacturers reported payments, led by Boston Scientific at 44.0% of the total. 2025 is the largest year on record at $5,123, more than ten times the $481 reported in 2019. Among pain medicine clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,065in general payments, 2019–2025

Across 125 payments — averaging $104.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$6K
Saluda Medical Americas, Inc.$2K
Abbott$2K
Medtronic$1K
Nevro Corp.$914
Nalu Medical, Inc.$497
plus $988 from 10 others

What the payments were for

Consulting fees$1,1609%
Travel & lodging$3,96730%
Food & beverage$7,93961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	61	$5,744
Saluda Medical Americas, Inc.	8	$2,016
Abbott	12	$1,725
Medtronic(2 entities)	3	$1,181
Nevro Corp.	20	$914
Nalu Medical, Inc.	4	$497
Vertos Medical, Inc.	3	$320
Pacira Pharmaceuticals Incorporated	2	$167
SPR Therapeutics, Inc	1	$149
Merck	4	$146
Stryker	1	$73
Globus Medical	1	$37
Convatec Inc.	1	$29
Vertex	1	$25
Lilly USA, LLC	2	$24
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$1,921
Evoke$1,878
GENERAL PAIN MANAGEMENT$1,181
PROCLAIM$1,155
Nalu Neurostimulation System$497
WaveWriter Alpha Prime 16$284
Omnia$279
SPECTRA WAVEWRITER$235
Proclaim Family of SCS IPGs$192
ETERNA$160
SPRINT PNS System$149
mild Device Kit$139
INTELLIS ADAPTIVESTIM$131
Senza Spinal Cord Stimulation System$127
Senza$120
EXPAREL$110
Intracept$107

How this compares

$13,065 in reported general payments places this provider in the 90th percentile of 38 pain medicine providers in New Hampshire.

See all pain medicine providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$106,492

Medicare patients

330

Services billed

1,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	16	$2,404
Oxycodone Hcl	50	$1,303
Pregabalin	28	$1,144
Gabapentin	65	$601
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$551
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$442
Tizanidine Hcl	31	$354
Tramadol Hcl	26	$331
Cyclobenzaprine Hcl	17	$243
Methocarbamol	14	$203
Diclofenac Sodium	11	$191
Nortriptyline Hcl	15	$124
Baclofen	16	$112

Paid to pharmacies, not to this prescriber.

Other pain medicine in Dover

Thomas ZoukiDover$9K
Jung KimDover$4K
Tennison MalcolmDover$3K
Aamir AbbasDover$2K
Praveen SuchdevNashua$72K
Zubin BatlivalaBedford$18K
Bert FichmanLebanon$15K
Michael BovaLebanon$12K
James MirazitaNashua$10K
Robert LehnPortsmouth$9K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →